The same active ingredient as Ozempic® and Wegovy® — at a fraction of the cost.
Semaglutide is a GLP-1 receptor agonist that was originally developed to treat type 2 diabetes. In clinical trials, researchers discovered it also produced significant weight loss, leading to its FDA approval for chronic weight management under the brand names Wegovy® and Ozempic®.
GLP-1 (glucagon-like peptide-1) is a hormone your body naturally produces after eating. It signals to your brain that you're full, slows digestion, and helps regulate blood sugar levels. Semaglutide mimics this hormone, helping you feel satisfied with less food.
Our compounded Semaglutide contains the same active ingredient as brand-name medications but is prepared by licensed 503A compounding pharmacies, making it available at a fraction of the retail cost.
Signals to your brain that you're full, naturally reducing hunger and cravings.
Food stays in your stomach longer, keeping you satisfied between meals.
Helps regulate insulin and blood sugar levels, reducing energy crashes.
15-20%
Average Body Weight Loss
In clinical trials, participants lost an average of 15-20% of their body weight over 68 weeks.
86%
Lost 5% or More
86% of participants achieved clinically meaningful weight loss of 5% or more.
*Based on STEP clinical trial results. Individual results may vary.
Semaglutide is gradually increased over several months to minimize side effects and optimize results.
| Month | Weekly Dose | Purpose |
|---|---|---|
| Month 1 | 0.25mg | Initiation - body adjustment |
| Month 2 | 0.5mg | First escalation |
| Month 3 | 1.0mg | Therapeutic dose begins |
| Month 4 | 1.7mg | Increased efficacy |
| Month 5+ | 2.4mg | Maintenance dose |
Your provider will customize your dosing schedule based on your individual response and tolerance.
Most side effects are mild and improve as your body adjusts to the medication.
Contact your provider immediately if you experience severe symptoms.
Ozempic®
$1,000+
/month
Wegovy®
$1,300+
/month
GetSlimRX
$179
/month
Save up to 85%